Evidence map›Paper›PMID 18436535›Full record

ArticleAmerican journal of epidemiology2008

Maternal asthma medication use and the risk of gastroschisis.

Shao Lin, Jean Pierre W Munsie, Michele L Herdt-Losavio, Erin Bell, Charlotte Druschel, Paul A Romitti, Richard Olney, National Birth Defects Prevention Study

Open access · bronzeAbstract read
In one paragraph

Article in American journal of epidemiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Interventions for managing asthma in pregnancy.The Cochrane database of systematic reviews · 2014
    Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Gastroschisis and Cumulative Stressor Exposures.Epidemiology (Cambridge, Mass.) · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Allergen immunotherapy in pregnancy.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2015
    Review
  14. Diagnosing rhinitis during pregnancy.Current allergy and asthma reports · 2014
    Review
  15. Review
  16. Article
  17. Article
  18. Asthma in pregnancy - from immunology to clinical management.Multidisciplinary respiratory medicine · 2010
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Shao LinCenter for Environmental Health, New York State Department of Health, Troy, NY 12180, USA. sxl05@health.state.ny.us
Jean Pierre W Munsie
Michele L Herdt-Losavio
Erin Bell
Charlotte Druschel
Paul A Romitti
Richard Olney
National Birth Defects Prevention Study
Center for Environmental Health · USNew York State Department of Health · USCenters for Disease Control and Prevention · USUniversity at Albany, State University of New York · USUniversity of Iowa · US

Funding

CTRS. OF EXCELL. FOR SUR., RES. SERVICE &EVAL. AIMED AT BIRTH DEFECTSU50DD713238 · DD · UNIVERSITY OF IOWA · PI ROMITTI, PAUL A · 1996 to 2008
$2.2M
NCBDD CDC HHS U01 DD000487NCBDD CDC HHS U50 DD713238PHS HHS U50CCU213244
6 · The paper itself

Abstract

The objective of this study was to examine the association between maternal asthma medication use during the periconceptional period and the risk of gastroschisis. In this case-control study, the authors used data on deliveries enrolled in the National Birth Defects Prevention Study (1997-2002) from eight collaborating centers. The cases included 381 infants with isolated gastroschisis, and the controls were 4,121 liveborn infants without malformations. The asthma medications used during the periconceptional period (1 month prepregnancy through the third pregnancy month) were divided into two groups, antiinflammatory and bronchodilator, and analyzed separately. Users of multiple asthma medications during the periconceptional period were also examined. Logistic regression was used to estimate odds ratios and 95% confidence intervals while controlling for maternal age, race/ethnicity, education, smoking, folic acid/vitamin use, and other vasoactive medications. Maternal bronchodilator use showed an elevated statistically significant risk of gastroschisis (adjusted odds ratio = 2.06, 95% confidence interval: 1.19, 3.59). No significant association was found between maternal use of asthma antiinflammatory medications and gastroschisis. Because information on maternal asthma status/severity was not available, the effects of disease on the risk of gastroschisis cannot be ruled out. Additional research is needed in determining whether a real risk exists and for guiding asthma treatment.

Indexed as

Maternal-Fetal ExchangeAdultAnti-Inflammatory AgentsAsthmaBronchodilator AgentsCase-Control StudiesFemaleGastroschisisHumansInfant, NewbornInterviews as TopicLife StyleLogistic ModelsMaleMaternal WelfarePregnancyAnti-Inflammatory AgentsBronchodilator Agents

Identifiers

PMID18436535
PMCPMC6067822
OpenAlexW4237563842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.